Nitrogen

Description

Nitrogen NF is a refrigerated liquid with the chemical name nitrogen and a CAS number of 7727-37-9. It is classified as a refrigerated gas. The cylinder temperature for storage should not exceed 52 °C (125 °F).

Uses and Indications

This drug is indicated for use in specific medical situations where the administration of Nitrogen is deemed necessary. It is essential that this drug be administered only by or under the supervision of a licensed practitioner who possesses expertise in the use and administration of Nitrogen. The practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Limitations of use include the potential hazards associated with Nitrogen administration, which may render it contraindicated in certain circumstances. There are no specific teratogenic or nonteratogenic effects reported for this drug.

Dosage and Administration

Administration of Nitrogen is to be conducted with caution, as it may pose hazards or be contraindicated in certain situations. It is intended for use solely by or under the supervision of a licensed practitioner who possesses experience in the use and administration of Nitrogen. This practitioner must be well-versed in the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

The route of administration for Nitrogen is via respiratory inhalation. Healthcare professionals should ensure that the administration technique is appropriate and that the patient is monitored for any adverse reactions during and after the inhalation process.

Contraindications

Administration of Nitrogen is contraindicated in patients who are not under the supervision of a licensed practitioner experienced in its use, including knowledge of the associated hazards, contraindications, side effects, and necessary precautions.

Additionally, the use of Nitrogen is contraindicated in situations where adequate ventilation cannot be ensured, or where equipment is not rated for cylinder pressure. It is essential to utilize a backflow preventive device in the piping and to ensure that the cylinder temperature does not exceed 52°C (125°F). Adherence to the Safety Data Sheet for this product is required to mitigate risks associated with its use.

Warnings and Precautions

The use of Nitrogen requires careful consideration of associated risks and necessary precautions to ensure safety during administration.

Warnings

Nitrogen is a refrigerated gas that poses significant risks, including the potential for cryogenic burns or injury. Additionally, it may displace oxygen in the environment, leading to rapid suffocation. The administration of Nitrogen may be hazardous or contraindicated; therefore, it should only be performed by or under the supervision of a licensed practitioner who possesses experience in its use. This practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, duration of administration, as well as the hazards, contraindications, side effects, and necessary precautions.

It is important to note that Nitrogen is stored under pressure, which presents an explosion risk if heated. The potential for oxygen displacement also necessitates vigilance to prevent rapid suffocation.

General Precautions

Prior to handling Nitrogen, all safety precautions must be thoroughly read and understood. It is imperative to use and store Nitrogen outdoors or in a well-ventilated area. Personal protective equipment, including cold insulating gloves, a face shield, and eye protection, should be worn at all times. A backflow preventive device must be utilized in the piping to prevent reverse flow. Connections should not be changed or forced, and the valve must be closed after each use and when the container is empty. The cylinder should always be maintained in an upright position, and the temperature of the cylinder must not exceed 52°C (125°F). All handling and usage should be conducted in accordance with the Safety Data Sheet for this product.

Transport, storage, and usage of Nitrogen must be conducted with adequate ventilation. Only equipment rated for cylinder pressure should be employed, and the same precautions regarding backflow prevention and valve closure apply.

Emergency Medical Help Instructions

In the event of inhalation, the affected individual should be removed to fresh air immediately. If the individual is not breathing, artificial respiration should be administered. If breathing difficulties arise, supplemental oxygen should be provided, and a physician should be contacted without delay.

If Nitrogen comes into contact with the skin, the affected areas should be thawed with lukewarm water; rubbing the area is contraindicated. Immediate medical advice and attention should be sought in such cases.

Stop Taking and Call Your Doctor Instructions

No specific instructions regarding cessation of use and consultation with a physician are provided.

Side Effects

Administration of Nitrogen may pose significant hazards and is contraindicated in certain situations. It is intended for use only by or under the supervision of a licensed practitioner who possesses experience in its administration, including knowledge of the associated hazards, contraindications, side effects, and necessary precautions.

Patients should exercise caution when transporting, storing, and using Nitrogen. Adequate ventilation is essential during use, and only equipment rated for cylinder pressure should be utilized. A backflow preventive device must be employed in the piping, and the valve should be closed after each use and when the cylinder is empty. It is critical to ensure that the cylinder temperature does not exceed 52°C (125°F) and to follow the guidelines outlined in the Safety Data Sheet for this product.

Adverse reactions associated with Nitrogen include the potential for oxygen displacement, which may lead to rapid suffocation. In the event of inhalation, it is imperative to remove the affected individual to fresh air immediately. If the individual is not breathing, artificial respiration should be administered, and if breathing difficulties arise, oxygen should be provided. Medical assistance should be sought promptly.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrogen, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

The administration of Nitrogen in pediatric patients may pose hazards or be contraindicated. It is essential that Nitrogen is used only by or under the supervision of a licensed practitioner who possesses experience in its use and administration. This practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions. Careful consideration and adherence to these guidelines are critical to ensure the safety and efficacy of Nitrogen in pediatric populations.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The administration of Nitrogen during pregnancy may pose potential risks and is contraindicated unless under the supervision of a licensed practitioner experienced in its use. Pregnant patients should be closely monitored due to the potential hazards associated with Nitrogen administration. It is essential that healthcare professionals are familiar with the indications, effects, dosages, methods, and frequency and duration of administration, as well as the associated contraindications and side effects.

Given the lack of specific data regarding the effects of Nitrogen on fetal outcomes, caution is advised when considering its use in women of childbearing potential. The decision to administer Nitrogen should involve a thorough assessment of the risks versus benefits, ensuring that the safety of both the mother and the fetus is prioritized.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. Further research may be necessary to fully understand the implications for breastfed infants.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary depending on the substance involved and the individual patient’s characteristics. Symptoms may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and conduct a thorough clinical examination. Supportive care should be initiated as necessary, which may include airway management, intravenous fluids, and monitoring of vital parameters.

If specific antidotes or treatments are available for the substance involved, they should be administered according to established protocols. Consultation with a poison control center or toxicology expert may also be warranted to guide management decisions.

It is crucial to document all findings and interventions in the patient's medical record to ensure continuity of care and facilitate further treatment if required.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to fully evaluate the nonclinical toxicology profile.

Postmarketing Experience

No specific postmarketing experience details have been reported. As such, there are no additional adverse events or rare case reports to summarize at this time.

Patient Counseling

Healthcare providers should advise patients to always keep the container in an upright position to ensure safety and proper functioning. It is crucial to emphasize the importance of reading and understanding all safety precautions before handling the product. Patients should be instructed to use and store the product only outdoors or in a well-ventilated area to minimize exposure to potentially harmful vapors.

Providers should recommend that patients wear appropriate protective gear, including cold insulating gloves, a face shield, and eye protection, when handling the product. Additionally, the use of a backflow preventive device in the piping is essential to prevent any hazardous situations.

Patients must be cautioned against changing or forcing connections, as this could lead to dangerous leaks or malfunctions. It is important to remind them to close the valve after each use and when the container is empty to prevent accidental release of the substance. The cylinder temperature should not exceed 52°C (125°F) to maintain safety standards.

Healthcare providers should instruct patients to use the product in accordance with the Safety Data Sheet provided for this product, which contains critical information regarding safe handling and emergency procedures.

In the event of an emergency, patients should be informed of the appropriate first aid measures. If inhaled, they should be removed to fresh air and kept comfortable for breathing. If the product comes into contact with skin, patients should thaw any frosted areas with lukewarm water without rubbing the affected area and seek immediate medical advice or attention.

Finally, it is imperative to communicate that the administration of Nitrogen may be hazardous or contraindicated. This product should only be used by or under the supervision of a licensed practitioner who is experienced in its use and administration, and who is knowledgeable about the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Storage and Handling

The product is supplied in a cylinder format, and it is essential to maintain the container in an upright position at all times. The temperature of the cylinder must not exceed 52°C (125°F) to ensure safe storage and handling. It is recommended to use and store the product exclusively outdoors or in a well-ventilated area to minimize risks associated with pressure buildup and potential hazards.

When transporting, storing, or using the product, adequate ventilation must be ensured to maintain safety standards. It is crucial to utilize equipment that is rated for cylinder pressure to prevent any incidents. After each use and when the cylinder is empty, the valve should be closed to prevent any unintended release of contents. Additionally, all handling and usage should be conducted in accordance with the Safety Data Sheet for this product to ensure compliance with safety protocols.

Additional Clinical Information

The route of administration for the medication is via respiratory inhalation. Clinicians should be aware that the administration of Nitrogen may pose hazards or be contraindicated. It is essential that this medication is used only by or under the supervision of a licensed practitioner who is experienced in its use. This practitioner should be knowledgeable about the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

No additional information is available regarding laboratory tests, abuse potential, or postmarketing experience.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrogen as submitted by Helget Gas Products. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)